Related Experiment Videos
High-dose chemotherapy. Concepts and strategies
American Journal of Clinical Oncology
|April 1, 1987
Summary
High-dose chemotherapy can improve cancer response rates, but toxicity and short response durations remain challenges. Further research into drug resistance and dose optimization is crucial for patient survival.
Area of Science:
- Oncology
- Pharmacology
- Cancer Therapeutics
Background:
- Chemosensitive malignancies exhibit steep dose-response curves in experimental models.
- Clinical observations indicate higher patient responses with increased conventional chemotherapy doses.
Purpose of the Study:
- To review factors and concepts related to the clinical use of high-dose chemotherapy.
- To explore strategies for enhancing chemotherapy efficacy and managing toxicity.
Main Methods:
- Review of existing literature on high-dose chemotherapy strategies.
- Analysis of dose-response relationships, drug scheduling, drug interactions, pharmacokinetics, and toxicity mitigation.
Main Results:
- High-dose chemotherapy can increase response rates but often leads to short response durations and no significant impact on survival.
- Autologous bone marrow transplant is a method to circumvent toxicity, introducing new dose-limiting toxicities.
- Drug resistance is multifactorial, with drug dose and concentration being key manipulable variables.
Conclusions:
- Increasing drug dose is a clinician-controlled variable crucial for enhancing cytotoxicity.
- High-dose chemotherapy may be most beneficial for consolidating drug-sensitive tumors with minimal residual disease.
- Continued exploration of high-dose chemotherapy is warranted, alongside a deeper understanding of drug resistance mechanisms.